China Stomach Acid Deficiency Treatment Market Size & Growth Rate
According to 6Wresearch internal database and industry insights, the China Stomach Acid Deficiency Treatment Market was valued at USD 610.0 million in 2025 and is projected to reach USD 954.18 million by 2032, growing at a CAGR of approximately 6.6% during 2026–2032.
China Stomach Acid Deficiency Treatment Market Highlights
| Report Metric | Details |
| Report Name | China Stomach Acid Deficiency Treatment Market |
| Market Size 2025 | USD 610.0 million |
| Market Size 2032 | USD 954.18 million |
| Absolute Growth 2025–2032 | USD 344.18 million |
| CAGR 2026–2032 | 6.6% |
| Peak Annual Growth | 9.1% in 2031 |
| Forecast Period | 2026–2032 |
| Historical Data | 2022–2025 |
| Base Year | 2025 |
| Leading Treatment Type, 2025 | Prescription Antacids (46% share) |
| Leading Drug Form, 2025 | Tablet (34% share) |
| Leading Sales Channel, 2025 | Pharmacies (42% share) |
| Leading End User, 2025 | Chronic GERD Patients (38% share) |
| Fastest-Growing Treatment Type | Digestive Enzyme Blends (7.6% CAGR) |
| Fastest-Growing Drug Form | Capsule (8.5% CAGR) |
| Fastest-Growing Sales Channel | Online Stores (8.0% CAGR) |
| Fastest-Growing End User | Gastroenterology Clinics (8.3% CAGR) |
| Growing Sector | Gastroenterology Clinics |
| Key End Users | Chronic GERD Patients, Nutraceutical Consumers, Gastroenterology Clinics, Functional Medicine Users |
China Stomach Acid Deficiency Treatment Market Year-wise Growth Rate and Key Drivers (2022–2032)
This graph illustrates the annual growth rates of the market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.
The table below sets out the estimated growth rate for each year and the main factor behind it.
| Year | Estimated Annual Growth (%) | Market Rationale |
| 2022 | 6.6 | The market experienced steady growth due to increasing awareness of digestive health among consumers. |
| 2023 | 7.0 | The launch of public health campaigns by the National Health Commission contributed to faster growth than the previous year. |
| 2024 | 7.5 | Growth accelerated as more gastroenterology clinics opened in urban areas, enhancing treatment access. |
| 2025 | 4.5 | A slowdown occurred as the market adjusted to increased competition in the supplement space. |
| 2026 | 4.3 | Growth is expected to continue slowing as consumer preferences shift towards online purchasing options. |
| 2027 | 5.0 | Demand is projected to rise as digestive health becomes a priority for healthcare providers and patients. |
| 2028 | 7.4 | The market is expected to rebound with increased interest in digestive enzyme blends and supplements. |
| 2029 | 8.3 | Growth is anticipated to accelerate again as more consumers seek effective solutions for GERD. |
| 2030 | 5.4 | The market is projected to slow as the focus shifts to quality over quantity in product offerings. |
| 2031 | 9.1 | A peak in growth is expected due to heightened awareness and new treatment options. |
| 2032 | 6.8 | Growth is projected to slow again as the market stabilises with established consumer habits. |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
China Stomach Acid Deficiency Treatment Market Synopsis
Stomach Acid Deficiency Treatment in China covers various products aimed at addressing low stomach acid levels through supplements and medications. These treatments alleviate symptoms of acid reflux, improve digestion, and support gastrointestinal health. The China Stomach Acid Deficiency Treatment Market is growing due to rising awareness of digestive health and increasing demand from healthcare providers. The prevalence of GERD in China, estimated at 10% of the adult population, drives market interest. Public health campaigns and the expansion of gastroenterology clinics further stimulate demand.
Market Dynamics Impact Analysis (2026–2032)
| Factor | Type | Impact | Primary Segment Affected |
| Increasing awareness of digestive health issues drives demand for effective treatments. | Driver | High | Prescription Antacids |
| The rise in online sales channels enhances product accessibility for consumers. | Driver | High | Online Stores |
| The growing population of chronic GERD patients presents a significant market opportunity. | Opportunity | High | Chronic GERD Patients |
| The increasing popularity of digestive enzyme blends opens new avenues for suppliers. | Opportunity | High | Digestive Enzyme Blends |
| Regulatory hurdles can delay the approval of new digestive health products. | Restraint | High | Betaine HCL Supplements |
| Consumer preference for natural remedies may limit the market for synthetic products. | Restraint | Medium | Prescription Antacids |
| Competition from alternative treatments can affect market share for traditional products. | Challenge | Medium | Herbal Remedies |
| The need for continuous education on digestive health can strain marketing resources. | Challenge | Medium | Digestive Enzyme Blends |
Evaluation of Drivers in China Stomach Acid Deficiency Treatment Market (2026–2032)
Below mentioned are some major drivers and their influence on market dynamics.
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Growing consumer awareness of digestive health issues increases demand for supplements. | Betaine HCL Supplements | In 2022, the average household expenditure on health supplements in urban China increased by 15%. |
| The expansion of gastroenterology clinics boosts the prescription of effective treatments. | Prescription Antacids | In 2022, there were over 1,200 registered gastroenterology clinics in China. |
| The rise in online shopping facilitates easier access to digestive health products. | Online Stores | Online sales of digestive health products increased by 30% in the last year. |
| Public health campaigns promote awareness of digestive health and available treatments. | Digestive Enzyme Blends | The National Health Commission launched a program to improve gastrointestinal health education in 2023. |
| The increasing prevalence of GERD among adults drives demand for effective solutions. | Chronic GERD Patients | The prevalence of GERD in China is estimated at 10% of the adult population. |
Market growth for Stomach Acid Deficiency Treatment in China is underpinned by rising consumer awareness of digestive health, the expansion of gastroenterology clinics, and increased online sales. In 2022, the average household expenditure on health supplements in urban China rose by 15%, leading to greater purchases of various digestive health products. The number of registered gastroenterology clinics exceeded 1,000, improving access to effective treatments. The prevalence of GERD, estimated at 10% of the adult population, drives demand for effective solutions.
Evaluation of Restraints in China Stomach Acid Deficiency Treatment Market
The main factors holding the market back are set out below.
| Market Restraint | Primary Segment Affected | Why It Matters (Evidence) |
| Regulatory hurdles delay the approval process for new digestive health products. | Betaine HCL Supplements | The National Medical Products Administration's standards can prolong product entry into the market. |
| Consumer preference for natural remedies limits the market for synthetic treatments. | Prescription Antacids | Health food stores report a growing demand for herbal remedies for digestive issues. |
| Competition from alternative treatments can dilute market share for established products. | Digestive Enzyme Blends | The rise of holistic health approaches challenges traditional treatment methods. |
| Limited awareness among certain demographics restricts market growth potential. | Herbal Remedies | Health awareness events focusing on digestive health are not universally accessible. |
| High marketing costs for educating consumers can strain budgets for suppliers. | Betaine HCL Supplements | Continuous education on digestive health requires substantial investment. |
China Stomach Acid Deficiency Treatment Market Challenges
The China Stomach Acid Deficiency Treatment market faces several challenges, starting with limited access to effective treatments. Many consumers in urban areas encounter delays in obtaining prescription antacids due to strict regulations, which can hinder their relief from digestive issues. Another concern is outdated manufacturing methods; producers often rely on traditional techniques, resulting in inconsistent product quality and a 15% increase in returns from dissatisfied customers. Supply chain disruptions also occur due to high demand for herbal remedies, leading to product shortages in health food stores. Regulatory compliance burdens suppliers, with stringent standards from the National Medical Products Administration potentially raising production costs by up to 20% for small manufacturers.
Trends in the China Stomach Acid Deficiency Treatment Market
Four trends stand out in the China Stomach Acid Deficiency Treatment Market.
- Shift Towards Online Sales Channels: The National Health Commission's 2023 initiative has led to a 30% increase in online sales of digestive health products. This shift allows consumers easier access to various treatments, indicating a preference for convenience in purchasing.
- Growing Demand for Digestive Enzyme Blends: In urban areas, the increasing prevalence of GERD has spurred interest in digestive enzyme blends. With a projected CAGR of 7.6% for this segment, more consumers are seeking effective solutions for digestive issues.
- Rise of Public Health Campaigns: Since 2021, the 'Healthy China 2030' initiative has focused on improving digestive health awareness. This programme has resulted in increased consumer education and a growing market for stomach acid deficiency treatments.
- Increased Focus on Gastroenterology Clinics: The establishment of over 1,000 gastroenterology clinics has improved access to treatments. This trend supports a growing patient base seeking effective solutions for digestive health.
Investment Opportunities in the China Stomach Acid Deficiency Treatment Market
The following opportunities in the China Stomach Acid Deficiency Treatment Market pair current demand with a clear way in.
- Collaboration with Healthcare Providers: The Chinese government has set a target to reduce gastrointestinal diseases by 20% by 2030. Collaborating with healthcare providers can improve treatment access for patients and expand market reach.
- Supply of Digestive Enzyme Blends: With a projected CAGR of 7.6%, the demand for digestive enzyme blends presents a valuable opportunity. Suppliers can target chronic GERD patients through partnerships with gastroenterology clinics.
- Entry into Online Sales: The online sales channel is growing rapidly, with a 30% increase in the last year. Suppliers should consider establishing partnerships with e-commerce platforms to meet rising consumer demand.
- Investment in Health Education: The average household expenditure on health supplements is increasing steadily. Investing in educational campaigns can attract nutraceutical consumers seeking effective digestive health solutions.
Government Initiatives in the China Stomach Acid Deficiency Treatment Market
In 2023, the National Medical Products Administration updated regulations to streamline the approval process for digestive health supplements. This measure builds on the 'Healthy China 2030' initiative from 2021, which aims to improve access to treatments and consumer education. The updated regulations facilitate quicker market entry for new products, benefiting both producers and consumers by ensuring a wider range of options. These changes help maintain high standards for product quality and safety, boosting consumer confidence in the market.
In 2022, the Ministry of Health approved new guidelines for the treatment of GERD, improving care standards for patients. The National Health Commission, through its various health education programmes, funds initiatives that promote awareness and access to effective treatments. These guidelines ensure that healthcare providers adhere to best practices, ultimately improving patient outcomes. Furthermore, the collaboration between agencies helps to create a more informed consumer base, driving demand for effective stomach acid deficiency treatments.
Future Insight of the China Stomach Acid Deficiency Treatment Market
The China Stomach Acid Deficiency Treatment market is expected to develop by 2032, driven by several key factors. The National Health Commission's gastrointestinal health education program will raise public awareness and boost demand for effective treatments. Technological advancements in supplement production will improve product quality and consistency, benefiting both suppliers and buyers. The trend of online sales, which surged by 30% last year, will continue to expand access to digestive health products. The government's target to reduce gastrointestinal diseases by 20% by 2030 will further stimulate market growth.
Market Segmentation Analysis
Each segment group is reviewed below, with the leader by share and the fastest grower by CAGR.
By Treatment Type – Prescription Antacids Dominated, Digestive Enzyme Blends Expected to Grow Fastest
According to Summon Dutta, Assistant Manager at 6Wresearch, in 2025, Prescription Antacids led the treatment type split with a 46% share. Prescription antacids dominate the market share as they are the preferred choice for chronic GERD patients seeking effective symptom relief. The high prevalence of GERD, affecting an estimated 10% of the adult population in China, drives consistent demand for these treatments. The quickest growth will come from Digestive Enzyme Blends, forecast to expand at a CAGR of 7.6% between 2026 and 2032. The rapid growth of digestive enzyme blends is propelled by increasing consumer awareness of their benefits in improving digestion. This is evidenced by a 30% rise in online sales of digestive health products, reflecting a shift towards these supplements. Suppliers should focus on enhancing product availability and educational efforts to meet the rising demand for effective digestive health solutions.
By Drug Form – Tablet Dominated, Capsule Expected to Grow Fastest
With a 34% revenue share in 2025, Tablet was the largest drug form category. Tablets capture the largest market share as they are the most commonly prescribed format, valued for their ease of consumption and widespread availability in pharmacies. This form is highly regarded by both healthcare providers and patients for its convenience and reliability. Over 2026–2032, Capsule is expected to post the fastest growth, at a CAGR of 8.5%. Capsules are experiencing the fastest growth due to their user-friendly nature and accurate dosage, appealing to health-conscious consumers. The trend towards more convenient formats is evident as patients increasingly seek efficient ways to manage their digestive health. Manufacturers should broaden their product lines to include more capsule options to meet the evolving preferences of consumers.
By Sales Channel – Pharmacies Dominated, Online Stores Expected to Grow Fastest
The largest sales channel category in 2025 was Pharmacies, with a 42% share of total revenue. Pharmacies lead the market share as the primary retail channel for over-the-counter treatments, providing essential access to consumers. Their established presence in urban areas ensures that patients can easily obtain necessary medications. Online Stores are projected to grow fastest, at a CAGR of 8.0% during 2026–2032. Online stores are rapidly gaining market share, highlighted by a 30% increase in online sales of digestive health products. This growth indicates a shift in shopping habits, particularly among younger consumers who prefer digital purchasing options. Retailers should enhance their online presence and marketing strategies to take advantage of the growing trend of e-commerce in the health supplement market.
By End User – Chronic GERD Patients Dominated, Gastroenterology Clinics Expected to Grow Fastest
Chronic GERD Patients held a 38% share of the China Stomach Acid Deficiency Treatment Market by end user in 2025. Chronic GERD patients constitute the largest user group for stomach acid deficiency treatments, driven by the high prevalence of the condition among adults. Their ongoing need for effective management options solidifies this segment's market share. Gastroenterology Clinics are set to record the highest CAGR in this split, 8.3% over 2026–2032. Gastroenterology clinics are experiencing the fastest growth as they become key providers for prescribing tailored treatments for digestive health. The increasing number of registered gastroenterology clinics in urban areas supports this upward trend. Healthcare providers should strengthen partnerships with gastroenterology clinics to ensure that patients receive appropriate treatment options.
Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- China Stomach Acid Deficiency Treatment Market Outlook
- Market Size of China Stomach Acid Deficiency Treatment Market, 2025
- Forecast of China Stomach Acid Deficiency Treatment Market, 2032
- Historical Data and Forecast of China Stomach Acid Deficiency Treatment Revenues & Volume for the Period 2022 - 2032F
- China Stomach Acid Deficiency Treatment Market Trend Evolution
- China Stomach Acid Deficiency Treatment Market Drivers and Challenges
- China Stomach Acid Deficiency Treatment Price Trends
- China Stomach Acid Deficiency Treatment Porter's Five Forces
- China Stomach Acid Deficiency Treatment Industry Life Cycle
- Historical Data and Forecast of China Stomach Acid Deficiency Treatment Market Revenues & Volume By Treatment Type for the Period 2022 - 2032F
- Historical Data and Forecast of China Stomach Acid Deficiency Treatment Market Revenues & Volume By Betaine HCL Supplements for the Period 2022 - 2032F
- Historical Data and Forecast of China Stomach Acid Deficiency Treatment Market Revenues & Volume By Digestive Enzyme Blends for the Period 2022 - 2032F
- Historical Data and Forecast of China Stomach Acid Deficiency Treatment Market Revenues & Volume By Prescription Antacids for the Period 2022 - 2032F
- Historical Data and Forecast of China Stomach Acid Deficiency Treatment Market Revenues & Volume By Herbal Remedies for the Period 2022 - 2032F
- Historical Data and Forecast of China Stomach Acid Deficiency Treatment Market Revenues & Volume By Drug Form for the Period 2022 - 2032F
- Historical Data and Forecast of China Stomach Acid Deficiency Treatment Market Revenues & Volume By Tablet for the Period 2022 - 2032F
- Historical Data and Forecast of China Stomach Acid Deficiency Treatment Market Revenues & Volume By Capsule for the Period 2022 - 2032F
- Historical Data and Forecast of China Stomach Acid Deficiency Treatment Market Revenues & Volume By Liquid for the Period 2022 - 2032F
- Historical Data and Forecast of China Stomach Acid Deficiency Treatment Market Revenues & Volume By Powder for the Period 2022 - 2032F
- Historical Data and Forecast of China Stomach Acid Deficiency Treatment Market Revenues & Volume By Sales Channel for the Period 2022 - 2032F
- Historical Data and Forecast of China Stomach Acid Deficiency Treatment Market Revenues & Volume By Online Stores for the Period 2022 - 2032F
- Historical Data and Forecast of China Stomach Acid Deficiency Treatment Market Revenues & Volume By Pharmacies for the Period 2022 - 2032F
- Historical Data and Forecast of China Stomach Acid Deficiency Treatment Market Revenues & Volume By Hospitals for the Period 2022 - 2032F
- Historical Data and Forecast of China Stomach Acid Deficiency Treatment Market Revenues & Volume By Health Food Stores for the Period 2022 - 2032F
- Historical Data and Forecast of China Stomach Acid Deficiency Treatment Market Revenues & Volume By End User for the Period 2022 - 2032F
- Historical Data and Forecast of China Stomach Acid Deficiency Treatment Market Revenues & Volume By Nutraceutical Consumers for the Period 2022 - 2032F
- Historical Data and Forecast of China Stomach Acid Deficiency Treatment Market Revenues & Volume By Gastroenterology Clinics for the Period 2022 - 2032F
- Historical Data and Forecast of China Stomach Acid Deficiency Treatment Market Revenues & Volume By Chronic GERD Patients for the Period 2022 - 2032F
- Historical Data and Forecast of China Stomach Acid Deficiency Treatment Market Revenues & Volume By Functional Medicine Users for the Period 2022 - 2032F
- China Stomach Acid Deficiency Treatment Import Export Trade Statistics
- Market Opportunity Assessment By Treatment Type
- Market Opportunity Assessment By Drug Form
- Market Opportunity Assessment By Sales Channel
- Market Opportunity Assessment By End User
- China Stomach Acid Deficiency Treatment Top Companies Market Share
- China Stomach Acid Deficiency Treatment Competitive Benchmarking By Technical and Operational Parameters
- China Stomach Acid Deficiency Treatment Company Profiles
- China Stomach Acid Deficiency Treatment Key Strategic Recommendations
Market Covered
Segments analysed in this report are listed below.
By Treatment Type
- Betaine HCL Supplements
- Digestive Enzyme Blends
- Prescription Antacids
- Herbal Remedies
By Drug Form
- Tablet
- Capsule
- Liquid
- Powder
By Sales Channel
- Online Stores
- Pharmacies
- Hospitals
- Health Food Stores
By End User
- Nutraceutical Consumers
- Gastroenterology Clinics
- Chronic GERD Patients
- Functional Medicine Users







